Regulation of Telomerase Alternative Splicing: A Target for Chemotherapy
Telomerase is present in human cancer cells but absent in most somatic tissues. The messenger RNA of human telomerase (hTERT) is alternatively spliced into mostly nonfunctional products. We sought to understand splicing so that we could decrease functional splice isoforms to reduce telomerase activi...
Main Authors: | Mandy S. Wong, Ling Chen, Christopher Foster, Radhika Kainthla, Jerry W. Shay, Woodring E. Wright |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2013-04-01
|
Series: | Cell Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211124713001186 |
Similar Items
-
An Alternate Splicing Variant of the Human Telomerase Catalytic Subunit Inhibits Telomerase Activity
by: Xiaoming Yi, et al.
Published: (2000-09-01) -
The Roles of Telomerase in the Generation of Polyploidy during Neoplastic Cell Growth
by: Agni Christodoulidou, et al.
Published: (2013-02-01) -
Telomerase-Mediated Strategy for Overcoming Non–Small Cell Lung Cancer Targeted Therapy and Chemotherapy Resistance
by: Ilgen Mender, et al.
Published: (2018-08-01) -
Quantification of alternative splicing variants of human telomerase reverse transcriptase and correlations with telomerase activity in lung cancer.
by: Yan Liu, et al.
Published: (2012-01-01) -
Insights into Telomerase/hTERT Alternative Splicing Regulation Using Bioinformatics and Network Analysis in Cancer
by: Andrew T. Ludlow, et al.
Published: (2019-05-01)